BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

864 related articles for article (PubMed ID: 16604564)

  • 21. Changing incidence rate of invasive lobular breast carcinoma among older women.
    Li CI; Anderson BO; Porter P; Holt SK; Daling JR; Moe RE
    Cancer; 2000 Jun; 88(11):2561-9. PubMed ID: 10861434
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A simple model of breast carcinoma growth may provide explanations for observations of apparently complex phenomena.
    Kopans DB; Rafferty E; Georgian-Smith D; Yeh E; D'Alessandro H; Moore R; Hughes K; Halpern E
    Cancer; 2003 Jun; 97(12):2951-9. PubMed ID: 12784329
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Trends in incidence and treatment of ductal carcinoma in situ of the breast in southeast Netherlands].
    Voogd AC; Crommelin MA; Repelaer van Driel OJ; Nolthenius-Puylaert MC; van der Heijden LH; Coebergh JW
    Ned Tijdschr Geneeskd; 2000 Apr; 144(14):659-63. PubMed ID: 10774294
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The relevance of occult axillary micrometastasis in ductal carcinoma in situ: a clinicopathologic study with long-term follow-up.
    Lara JF; Young SM; Velilla RE; Santoro EJ; Templeton SF
    Cancer; 2003 Nov; 98(10):2105-13. PubMed ID: 14601079
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinicopathologic analysis of breast lesions associated with multiple papillomas.
    Ali-Fehmi R; Carolin K; Wallis T; Visscher DW
    Hum Pathol; 2003 Mar; 34(3):234-9. PubMed ID: 12673557
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lobular carcinoma in situ at percutaneous breast biopsy: surgical biopsy findings.
    Liberman L; Sama M; Susnik B; Rosen PP; LaTrenta LR; Morris EA; Abramson AF; Dershaw DD
    AJR Am J Roentgenol; 1999 Aug; 173(2):291-9. PubMed ID: 10430122
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lobular carcinoma in situ on core biopsy-what is the clinical significance?
    O'Driscoll D; Britton P; Bobrow L; Wishart GC; Sinnatamby R; Warren R
    Clin Radiol; 2001 Mar; 56(3):216-20. PubMed ID: 11247699
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fine-needle aspiration cytology of lobular carcinoma in situ.
    Ustün M; Berner A; Davidson B; Risberg B
    Diagn Cytopathol; 2002 Jul; 27(1):22-6. PubMed ID: 12112810
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Carcinoma in situ of the female breast. 10 year follow-up results of a prospective nationwide study.
    Ottesen GL; Graversen HP; Blichert-Toft M; Christensen IJ; Andersen JA
    Breast Cancer Res Treat; 2000 Aug; 62(3):197-210. PubMed ID: 11072784
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Familial breast carcinoma risks by morphology: a nationwide epidemiologic study from Sweden.
    Hemminki K; Granström C
    Cancer; 2002 Jun; 94(11):3063-70. PubMed ID: 12115398
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk of recurrence after ductal carcinoma in situ of the breast.
    Habel LA; Daling JR; Newcomb PA; Self SG; Porter PL; Stanford JL; Seidel K; Weiss NS
    Cancer Epidemiol Biomarkers Prev; 1998 Aug; 7(8):689-96. PubMed ID: 9718221
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of chromosome aneuploidy in tissue sections of preinvasive breast carcinomas using interphase cytogenetics.
    Visscher DW; Wallis TL; Crissman JD
    Cancer; 1996 Jan; 77(2):315-20. PubMed ID: 8625240
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incidental finding of mammary carcinoma in lumpectomy specimens.
    Tang P; Hajdu SI; Conte CC; Filardi DA
    Ann Clin Lab Sci; 2003; 33(1):23-31. PubMed ID: 12661895
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk of mortality by histologic type of breast cancer among women aged 50 to 79 years.
    Li CI; Moe RE; Daling JR
    Arch Intern Med; 2003 Oct; 163(18):2149-53. PubMed ID: 14557212
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Minimal breast cancer: advance or anachronism?
    Wolmark N
    Can J Surg; 1985 May; 28(3):252-5. PubMed ID: 2986808
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Breast carcinoma-in-situ: an emerging problem in Singapore.
    Chua CL; Tan PK; Chiang G; Soo KC; Low CH
    Singapore Med J; 1992 Aug; 33(4):383-5. PubMed ID: 1329232
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mammary endocrine ductal carcinoma in situ: a case report.
    Danikas D; Matthews WE; Averbach DJ
    Am Surg; 2000 Dec; 66(12):1163-4. PubMed ID: 11149590
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protein expression and molecular analysis of c-myc gene in primary breast carcinomas using immunohistochemistry and differential polymerase chain reaction.
    Naidu R; Wahab NA; Yadav M; Kutty MK
    Int J Mol Med; 2002 Feb; 9(2):189-96. PubMed ID: 11786932
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognosis in women with a carcinoma in situ of the breast: a population-based study in Sweden.
    Wärnberg F; Bergh J; Holmberg L
    Cancer Epidemiol Biomarkers Prev; 1999 Sep; 8(9):769-74. PubMed ID: 10498395
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk factors for subsequent invasive breast cancer and breast cancer death after ductal carcinoma in situ: a population-based case-control study in Sweden.
    Wärnberg F; Bergh J; Zack M; Holmberg L
    Cancer Epidemiol Biomarkers Prev; 2001 May; 10(5):495-9. PubMed ID: 11352860
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 44.